CirChem AB Statistics
Total Valuation
CirChem AB has a market cap or net worth of SEK 45.03 million. The enterprise value is 44.28 million.
| Market Cap | 45.03M |
| Enterprise Value | 44.28M |
Important Dates
The last earnings date was Friday, February 13, 2026.
| Earnings Date | Feb 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CirChem AB has 40.21 million shares outstanding. The number of shares has increased by 21.78% in one year.
| Current Share Class | 40.21M |
| Shares Outstanding | 40.21M |
| Shares Change (YoY) | +21.78% |
| Shares Change (QoQ) | +0.75% |
| Owned by Insiders (%) | 1.87% |
| Owned by Institutions (%) | n/a |
| Float | 39.45M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.95 |
| PB Ratio | 1.02 |
| P/TBV Ratio | 1.02 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -3.67 |
| EV / Sales | 2.90 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -2.15 |
Financial Position
The company has a current ratio of 1.39, with a Debt / Equity ratio of 0.29.
| Current Ratio | 1.39 |
| Quick Ratio | 1.31 |
| Debt / Equity | 0.29 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.63 |
| Interest Coverage | -13.09 |
Financial Efficiency
Return on equity (ROE) is -26.77% and return on invested capital (ROIC) is -12.92%.
| Return on Equity (ROE) | -26.77% |
| Return on Assets (ROA) | -10.72% |
| Return on Invested Capital (ROIC) | -12.92% |
| Return on Capital Employed (ROCE) | -19.57% |
| Weighted Average Cost of Capital (WACC) | 15.93% |
| Revenue Per Employee | 1.17M |
| Profits Per Employee | -926,923 |
| Employee Count | 13 |
| Asset Turnover | 0.23 |
| Inventory Turnover | 60.96 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -66.06% in the last 52 weeks. The beta is 2.68, so CirChem AB's price volatility has been higher than the market average.
| Beta (5Y) | 2.68 |
| 52-Week Price Change | -66.06% |
| 50-Day Moving Average | 1.01 |
| 200-Day Moving Average | 1.56 |
| Relative Strength Index (RSI) | 50.90 |
| Average Volume (20 Days) | 155,935 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CirChem AB had revenue of SEK 15.26 million and -12.05 million in losses. Loss per share was -0.33.
| Revenue | 15.26M |
| Gross Profit | -2.14M |
| Operating Income | -11.20M |
| Pretax Income | -12.05M |
| Net Income | -12.05M |
| EBITDA | -10.08M |
| EBIT | -11.20M |
| Loss Per Share | -0.33 |
Balance Sheet
The company has 13.65 million in cash and 12.90 million in debt, with a net cash position of 751,000 or 0.02 per share.
| Cash & Cash Equivalents | 13.65M |
| Total Debt | 12.90M |
| Net Cash | 751,000 |
| Net Cash Per Share | 0.02 |
| Equity (Book Value) | 44.33M |
| Book Value Per Share | 1.10 |
| Working Capital | 4.73M |
Cash Flow
In the last 12 months, operating cash flow was -13.70 million and capital expenditures -6.88 million, giving a free cash flow of -20.58 million.
| Operating Cash Flow | -13.70M |
| Capital Expenditures | -6.88M |
| Free Cash Flow | -20.58M |
| FCF Per Share | -0.51 |
Margins
Gross margin is -14.04%, with operating and profit margins of -73.39% and -78.95%.
| Gross Margin | -14.04% |
| Operating Margin | -73.39% |
| Pretax Margin | -78.95% |
| Profit Margin | -78.95% |
| EBITDA Margin | -66.05% |
| EBIT Margin | -73.39% |
| FCF Margin | n/a |
Dividends & Yields
CirChem AB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -21.78% |
| Shareholder Yield | -21.78% |
| Earnings Yield | -26.76% |
| FCF Yield | -45.69% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CirChem AB has an Altman Z-Score of 1.35. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.35 |
| Piotroski F-Score | n/a |